MOLINA HEALTHCARE, INC. Shares Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • June 5th, 2015 • Molina Healthcare Inc • Hospital & medical service plans • New York
Contract Type FiledJune 5th, 2015 Company Industry Jurisdictionto me as originals and the conformity to original documents of all documents submitted to me as certified or photostatic copies and the authenticity of the originals of such copies. In making my examination of documents executed by parties other than the Company, I have assumed that such parties had the power, corporate or other, to enter into and perform all obligations under such documents and have also assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof. As to any facts material to this opinion which I did not independently establish or verify, I have relied upon statements and representations of the Company and its subsidiaries and their respective officers and other representatives and of public officials.
Capitala Finance Corp. 3,500,000 Shares Common Stock ($0.01 par value per Share)Underwriting Agreement • April 8th, 2015 • Capitala Finance Corp. • New York
Contract Type FiledApril 8th, 2015 Company Jurisdiction
INSTALLED BUILDING PRODUCTS, INC. [—] Shares Common Stock ($0.01 par value per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 2014 • Installed Building Products, Inc. • General bldg contractors - residential bldgs • New York
Contract Type FiledFebruary 3rd, 2014 Company Industry Jurisdiction
RUBICON TECHNOLOGY, INC. 2,650,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • January 8th, 2014 • Rubicon Technology, Inc. • Semiconductors & related devices • New York
Contract Type FiledJanuary 8th, 2014 Company Industry JurisdictionRubicon Technology, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Canaccord Genuity Inc. and the other underwriters, if any, listed on Schedule A attached hereto (collectively, the “Underwriters”) pursuant to this Underwriting Agreement (this “Agreement”) an aggregate of 2,650,000 shares (the “Firm Shares”) of common stock, $0.001 par value (the “Common Stock”), of the Company. In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional 397,500 shares of Common Stock (the “Additional Shares”). The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The Shares are described in the Prospectus which is referred to below.
FORM OF UNDERWRITING AGREEMENT] CAPITALA FINANCE CORP. 4,000,000 Shares Common Stock ($0.01 par value per Share) UNDERWRITING AGREEMENT September __, 2013Underwriting Agreement • September 24th, 2013 • Capitala Finance Corp. • New York
Contract Type FiledSeptember 24th, 2013 Company JurisdictionEach of Capitala Finance Corp., a Maryland corporation (the “Company”), CapitalSouth Partners Fund II Limited Partnership, a North Carolina limited partnership (“Fund II”), CapitalSouth Partners SBIC Fund III, L.P., a Delaware limited partnership (“Fund III”), Capitala Investment Advisors, LLC, a Delaware limited liability company (the “Advisor”), which has registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”), and Capitala Advisors Corp., a North Carolina corporation (the “Administrator” and, together with the Company, Fund II, Fund III and the Advisor, the “Capitala Entities”) confirms its agreement with the underwriters named in Schedule A annexed hereto (the “Underwriters”), for whom you are acting as representatives, with respect to the issue and sale by the Company to the Underwriters of an aggregate 4,000,000 shares (the “Firm Shares”) of common stock, $0.01 par value per share (th
PHOTOMEDEX, INC. 2,082,522 Shares Common Stock ($0.01 par value) Underwriting AgreementUnderwriting Agreement • April 24th, 2012 • Photomedex Inc • Electromedical & electrotherapeutic apparatus • Massachusetts
Contract Type FiledApril 24th, 2012 Company Industry Jurisdiction
BANCOLOMBIA S.A. 17,788,008 Preferred Shares (Ps.500 par value per share) in the form of American Depositary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2012 • Bancolombia Sa • Commercial banks, nec • New York
Contract Type FiledFebruary 6th, 2012 Company Industry Jurisdiction
INTERMUNE, INC. 3,500,000 Shares UNDERWRITING AGREEMENTUnderwriting Agreement • February 17th, 2009 • Intermune Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 17th, 2009 Company Industry Jurisdiction
MFRESIDENTIAL INVESTMENTS, INC. 16,666,667 Shares Common Stock ($0.01 par value per Share) FORM OF Underwriting Agreement May •, 2008Underwriting Agreement • May 19th, 2008 • MFResidential Investments, Inc. • Real estate investment trusts • New York
Contract Type FiledMay 19th, 2008 Company Industry JurisdictionMFResidential Investments, Inc., a Maryland corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule A annexed hereto (the “Underwriters”), for whom you are acting as representatives, an aggregate of 16,666,667 shares (the “Firm Shares”) of common stock, $0.01 par value per share (the “Common Stock”), of the Company. In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional 2,500,000 shares of Common Stock (the “Additional Shares”). The Firm Shares and the Additional Shares are hereinafter collectively sometimes referred to as the “Shares.” The Shares are described in the Prospectus which is referred to below.
WEST PHARMACEUTICAL SERVICES, INC. $150,000,000 Principal Amount 4.00% Convertible Junior Subordinated Debentures due 2047 UNDERWRITING AGREEMENTUnderwriting Agreement • March 14th, 2007 • West Pharmaceutical Services Inc • Fabricated rubber products, nec • New York
Contract Type FiledMarch 14th, 2007 Company Industry JurisdictionThis Lock-Up Agreement is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) to be entered into by West Pharmaceutical Services, Inc., a Pennsylvania corporation (the “Company”), and you and the other Underwriters named in Schedule A to the Underwriting Agreement, with respect to the public offering (the “Offering”) of Convertible Junior Subordinated Debentures (the “Debentures”) of the Company. Capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Underwriting Agreement.